Skip to main content

Advertisement

Table 4 IL-2 mean values and standard deviation (SD): difference between treatment group (aVQ) and control group of the 4 visits by independent t -test

From: Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma – a randomized, controlled pilot study

  IL-2 concentration in pg/ml (mean, (SD), median) t-test
  aVQ Control t p
Baseline 1.04 (0.56) 0.89 0.94 (0.44) 0.85 −0.5804 0.5662
Visit 2 59.08 (219.95) 0.93 0.76 (0.52) 0.56 −1.0269 0.3219
Visit 3 243.46 (702.12) 0.75 0.55 (0.42) 0.42 −1.3399 0.2016
Visit 4 70.84 (267.49) 0.81 0.46 (0.38) 0.75 −1.0190 0.3255
  1. IL-2: interleukin-2.